Using tissue microarray (TMA)-based immunohistochemistry on two independent cohorts of 879 patients with HCC, in vitro experiments and mice models, we intended to disclose the relevant clinical significance of PBK, to investigate the biological function and the underlying mechanism of PBK in the progression of HCC. The gene discussed is PBK; the disease is hepatocellular carcinoma.